US EditionPublished • loading... • Updated
Minerva Biotechnologies - Overcoming the Solid Tumor Barrier: MUC1*-Targeted CAR T bearing 1XX mutations overcomes exhaustion and enables killing of low antigen expressing cancer cells
Summary by Hastings Tribune
2 Articles
2 Articles
Minerva Biotechnologies - Overcoming the barrier of solid tumours: CAR-T cells targeted at MUC1* with 1XX mutations overcome exhaustion and allow the elimination of cancer cells with low antigen expression
·Italy
Read Full Article
Coverage Details
Total News Sources2
Leaning Left0Leaning Right1Center1Last UpdatedBias Distribution50% Center, 50% Right
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
50% Right
C 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
